Detalles de la búsqueda
1.
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia.
Ann Hematol
; 103(5): 1613-1622, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308707
2.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Histopathology
; 78(4): 567-577, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32936950
3.
Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts - the CONFIDENCE study protocol.
BMC Neurol
; 20(1): 95, 2020 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171264
4.
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
Front Neurol
; 13: 863105, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35614917
5.
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma.
Clin Genitourin Cancer
; 18(5): e629-e642, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32178978
6.
Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis.
Ther Adv Neurol Disord
; 12: 1756286419892077, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903096
7.
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
Virchows Arch
; 475(5): 599-608, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31267201
Resultados
1 -
7
de 7
1
Próxima >
>>